Literature DB >> 26183750

Idiopathic cholestatic jaundice may be a paraneoplastic manifestation of underlying malignancy: a case of prostate cancer.

Akihiro Okano1, Masaya Ohana, Fusako Kusumi.   

Abstract

A 68-year-old male was admitted to our hospital because of jaundice. Laboratory examinations revealed elevated total bilirubin (23.4 mg/dl) and hepatobiliary enzymes levels. Abdominal ultrasonography and computed tomography showed no abnormal finding in the liver and biliary ducts. Abdominal imaging examinations revealed a prostate tumor, and paraaortic and iliac lymph nodes enlargement. An elevated prostate-specific antigen (PSA) level of 15,018.0 ng/ml, followed by a positive prostate biopsy, confirmed prostate cancer. Histological examination of the liver biopsy showed non-specific inflammation of the portal area and sinusoid. We regarded the cholestatic jaundice as a paraneoplastic manifestation of the prostate cancer because of parallel dramatic decline of total bilirubin, hepatobiliary enzymes, and PSA levels after the initiation of anti-androgen treatment to the prostate cancer. Paraneoplastic syndrome should be included in the differential diagnosis of idiopathic cholestasis.

Entities:  

Mesh:

Year:  2014        PMID: 26183750     DOI: 10.1007/s12328-014-0484-4

Source DB:  PubMed          Journal:  Clin J Gastroenterol        ISSN: 1865-7265


  14 in total

1.  Paraneoplastic hepatic dysfunction in metastatic prostate cancer: the role of cytokine dysregulation.

Authors:  Vi Nguyen; Howard Gurney; David van der Poorten
Journal:  J Clin Oncol       Date:  2010-10-12       Impact factor: 44.544

2.  Paraneoplastic liver dysfunction in prostate cancer.

Authors:  Sanjay H Shah
Journal:  J Pain Symptom Manage       Date:  2006-12       Impact factor: 3.612

3.  Chronic lymphocytic leukemia presenting as jaundice.

Authors:  J Pandey; K T Bhowmik
Journal:  Indian J Gastroenterol       Date:  1998-01

Review 4.  Jaundice as a paraneoplastic phenomenon in a T-cell lymphoma.

Authors:  J Watterson; J R Priest
Journal:  Gastroenterology       Date:  1989-11       Impact factor: 22.682

5.  Fulminant hepatic failure as a presenting paraneoplastic manifestation of Hodgkin's disease.

Authors:  S P Dourakis; E Tzemanakis; M Deutsch; G Kafiri; S J Hadziyannis
Journal:  Eur J Gastroenterol Hepatol       Date:  1999-09       Impact factor: 2.566

6.  Sinusoidal dilatation of the liver as a paraneoplastic manifestation of renal cell carcinoma.

Authors:  T Aoyagi; I Mori; Y Ueyama; N Tamaoki
Journal:  Hum Pathol       Date:  1989-12       Impact factor: 3.466

Review 7.  [Cholestasis and prostatic carcinoma. Description of a case and review of paraneoplastic cholestasis].

Authors:  J Morís de la Tassa; I Claros González; M L García-Alcalde Fernández; A Antuña Egocheaga; M Argüelles Toraño
Journal:  Med Clin (Barc)       Date:  1991-01-12       Impact factor: 1.725

8.  Interleukin-6: a candidate mediator of human prostate cancer morbidity.

Authors:  D A Twillie; M A Eisenberger; M A Carducci; W S Hseih; W Y Kim; J W Simons
Journal:  Urology       Date:  1995-03       Impact factor: 2.649

9.  Paraneoplastic cholestasis associated with prostate carcinoma.

Authors:  Mehmet Koruk; Mehmet Büyükberber; Cemil Savaş; Abdurrahman Kadayifçi
Journal:  Turk J Gastroenterol       Date:  2004-03       Impact factor: 1.852

10.  Cholestatic jaundice as a paraneoplastic manifestation of prostate adenocarcinoma.

Authors:  Apostolos Karakolios; Christos Kasapis; Theofilos Kallinikidis; Panagiotis Kalpidis; Nikolaos Grigoriadis
Journal:  Clin Gastroenterol Hepatol       Date:  2003-11       Impact factor: 11.382

View more
  2 in total

1.  Cholestatic Jaundice as a Paraneoplastic Manifestation of Prostate Cancer Aggravated by Steroid Therapy.

Authors:  Min Kyu Kang; Jung Gil Park; Heon Ju Lee
Journal:  Med Princ Pract       Date:  2018-01-10       Impact factor: 1.927

2.  Paraneoplastic hyperbilirubinemia in metastatic prostate cancer and review of the current literature.

Authors:  Pınar Gökçen; Kaan Gökçen; Erol Çakmak; Gökhan Gökçe
Journal:  Turk J Urol       Date:  2018-09-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.